Berggruen Holdings — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.
AI & Machine LearningBiotechDeep TechLondon
Harrison Rickerby(Executive Officer, Director)
BoardJames Field(Founder)in
Co-investorsAcequia Capital (AceCap)Air Street CapitalAtomicoBackedBeast VenturesChampion Hill Ventures+10 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Mirror Emoji Keyboard
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






